Beijing-headquartered Chinese private equity firm Hony Capital has completed a partial exit from Hong Kong-listed Chinese generic drugs maker CSPC Pharmaceutical Group, selling 705.88 million shares for a total proceeds of HK$4.41 billion (US$570 million), according to a regulatory filing. Hony Capital unloaded 600 million CSPC shares to other third-party investors and 105.88 million shares […]

Visit for more great China Money Podcast audio and video Internet episodes covering important investment news and financial events in China, as well as daily news updates on important China business news happenings. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.

Visit the original source and full text: China Money Network